Noninvasive assessment of the infarct-related coronary artery blood flow velocity using phase-contrast magnetic resonance imaging after coronary angioplasty
Ap. Furber et al., Noninvasive assessment of the infarct-related coronary artery blood flow velocity using phase-contrast magnetic resonance imaging after coronary angioplasty, AM J CARD, 84(1), 1999, pp. 24-30
Citations number
27
Categorie Soggetti
Cardiovascular & Respiratory Systems","Cardiovascular & Hematology Research
This study assesses infarct-related coronary artery blood flow velocity usi
ng phase-contrast magnetic resonance imaging (MRI) in patients with reperfu
sed acute myocardial infarction (AMI) and compares these results with flow
measurements obtained nonsimultaneously by intracoronary Doppler ultrasound
. MRI examination was performed in 17 patients with AMI within 1 to 4 days
(mean 2.5 days) after direct or rescue coronary angioplasty using a 0.014-i
n Doppler guidewire. MRI was performed on a 1.5-T clinical imager. The fast
gradient echo segmented k-space phase-contrast pulse sequence was employed
during breath-hold. The MRI and Doppler parameters of average peak velocit
y and maximum peak velocity were measured. Mean phase contrast MRI average
peak velocity was 13.3 +/- 10.7 cm/s, and mean phase-contrast MRI maximum p
eak velocity was 27 +/- 16.6 cm/s. Mean Doppler average peak velocity was 1
7.1 +/- 5.1 cm/s, and mean Doppler maximum peak velocity was 35.5 +/- 10.1
cm/s. At the same anatomic levels, phase-contrast MRI average peak velocity
correlated significantly to Doppler average peak velocity (r = 0.52; p <0.
006) and Doppler maximum peak velocity (r = 0.42; p <0.03). Phase-contrast
MRI velocity measurements were correlated with the same heterogeneity of Th
rombolysis In Myocardial Infarction 3 flow velocity observed during Doppler
examination. Thus, by comparing phase-contrast MRI with invasive intracoro
nary Doppler flow measurements, the measured MRI values showed significant
correlation with Doppler data. Phase-contrast MRI has the potential to noni
nvasively quantify coronary flow velocity and to evaluate quality of reperf
usion in patients with AMI after reperfused therapy. (C) 1999 by Excerpta M
edica, Inc.